Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093496
Status:
COMPLETED
Last Update Posted:
2014-05-20
First Post:
2004-10-06
Brief Title:
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Ovarian Epithelial Cancer |
| Primary Peritoneal Cavity Cancer |
| Recurrent Ovarian Epithelial Cancer |
| Stage III Ovarian Epithelial Cancer |
Keywords: